Literature DB >> 10946257

Expression of human complement receptor 2 (CR2, CD21) in Cr2-/- mice restores humoral immune function.

K J Marchbank1, C C Watson, D F Ritsema, V M Holers.   

Abstract

Complement receptor type 2 (CR2, CD21) is expressed by both human and murine B cells and has been demonstrated to play a pivotal role in the humoral immune response. We have reconstituted Cr2-/- mice with an 80-kb human genomic fragment (designated P1-5) containing the full-length human CR2 (hCR2) gene. Transfection of P1-5 into the mouse A20 B cell line confirmed that it would direct expression of the hCR2 protein in mouse B cells. Immunoprecipitation analysis in these cells revealed that hCR2 coassociates with mouse CD19. After creation of transgenic mice using P1-5, we found significant expression of hCR2 on peripheral blood and splenic B cells by flow cytometric analysis. RT-PCR analysis of tissues and purified cell populations from transgene-positive mice revealed that hCR2 expression was restricted to B cells and the spleen in a pattern that matches mouse CR2. To rigorously assess the functional capabilities of hCR2, the transgene was bred onto Cr2-/- mice, which have a notable defect in response to SRBC Ag. We found that Cr2-/- mice expressing hCR2 had a substantial restoration of the humoral immune response to SRBC as compared with nontransgenic Cr2-/- littermate controls. Overall, this study suggests that hCR2 is able to substitute for mouse CR2 in the murine immune system. Therefore, hCR2-transgenic mice offer a valuable model system to further examine immunologic roles as well as structure-function relationships important for hCR2 function in primary cells in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10946257     DOI: 10.4049/jimmunol.165.5.2354

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Complement receptors and the shaping of the natural antibody repertoire.

Authors:  V Michael Holers
Journal:  Springer Semin Immunopathol       Date:  2004-12-22

2.  Depletion of complement has distinct effects on the primary and secondary antibody responses to a conjugate of pneumococcal serotype 14 capsular polysaccharide and a T-cell-dependent protein carrier.

Authors:  Samuel T Test; Joyce K Mitsuyoshi; Yong Hu
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  Defective B cell ontogeny and immune response in human complement receptor 2 (CR2, CD21) transgenic mice is partially recovered in the absence of C3.

Authors:  Jason Twohig; Liudmila Kulik; Catherine Haluszczak; Jason Reuter; Andreas Rossbach; Melanie Bull; V Michael Holers; Kevin J Marchbank
Journal:  Mol Immunol       Date:  2007-03-26       Impact factor: 4.407

4.  Modulation of mouse endotoxic fever by complement.

Authors:  S Li; V M Holers; S A Boackle; C M Blatteis
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

5.  Mice expressing human CR1/CD35 have an enhanced humoral immune response to T-dependent antigens but fail to correct the effect of premature human CR2 expression.

Authors:  Isabel Y Pappworth; Christine Hayes; Jason Dimmick; B Paul Morgan; V Michael Holers; Kevin J Marchbank
Journal:  Immunobiology       Date:  2011-06-25       Impact factor: 3.144

6.  Optimal germinal center B cell activation and T-dependent antibody responses require expression of the mouse complement receptor Cr1.

Authors:  Luke R Donius; Jennifer M Handy; Janis J Weis; John H Weis
Journal:  J Immunol       Date:  2013-06-03       Impact factor: 5.422

7.  Defective B cell ontogeny and humoral immune response in mice prematurely expressing human complement receptor 2 (CR2, CD21) is similar to that seen in aging wild type mice.

Authors:  Jason P Twohig; Isabel Y Pappworth; Baalasubramanian Sivasankar; Liudmila Kulik; Melanie Bull; V Michael Holers; Eddie C Y Wang; Kevin J Marchbank
Journal:  Mol Immunol       Date:  2009-04-08       Impact factor: 4.407

8.  Transcriptomic analysis of peritoneal cells in a mouse model of sepsis: confirmatory and novel results in early and late sepsis.

Authors:  Minny Bhatty; Ruping Fan; William M Muir; Stephen B Pruett; Bindu Nanduri
Journal:  BMC Genomics       Date:  2012-09-25       Impact factor: 3.969

9.  Increased B cell deletion and significantly reduced auto-antibody titre due to premature expression of human complement receptor 2 (CR2, CD21).

Authors:  Isabel Y Pappworth; Liudmila Kulik; Catherine Haluszczak; Jason W Reuter; V Michael Holers; Kevin J Marchbank
Journal:  Mol Immunol       Date:  2009-02-01       Impact factor: 4.407

10.  Restricted expression of Epstein-Barr virus latent genes in murine B cells derived from embryonic stem cells.

Authors:  Magdalena Zychlinska; Heidrun Herrmann; Ursula Zimber-Strobl; Wolfgang Hammerschmidt
Journal:  PLoS One       Date:  2008-04-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.